生物性骨材市場規模、佔有率、成長分析（按產品類型、按類型、按應用、按最終用戶、按地區）- 產業預測 2025-2032

2023 年全球生物性骨材市場規模價值 83 億美元，預計將從 2024 年的 87.8 億美元成長到 2032 年的 137.9 億美元，預測期內（2025-2032 年）的複合年成長率為 5.8%。

生物性骨材市場涵蓋促進肌肉骨骼疾病治癒的產品，預計由於再生醫學的進步、人口老化和整形外科手術的增加，該市場將經歷顯著成長。主要產品包括幹細胞、骨移植和 PRP（富含血漿的血小板）療法。然而，嚴格的監管核准、缺乏標準化以及治療成本高等挑戰可能會阻礙市場擴張。儘管存在這些障礙，但由於應用機會的激增、研發力度的加強以及個人化醫療趨勢的日益增強，該領域有望蓬勃發展。因此，預計整個預測期內市場動態將經歷顯著成長，反映肌肉骨骼健康治療方案的動態和不斷發展的前景。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究

生物性骨材市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概覽
• 去礦物質骨基質（DBM）
• 同種異體移植
• 骨形成蛋白（BMP）
• 關節內粘稠補充療法
• 合成骨替代物
• 幹細胞療法

生物性骨材市場規模（按類型及複合年成長率） (2025-2032)

• 市場概覽
• 膝蓋
• 踝
• 時髦的
• 手腕和肩膀
• 脊椎
• 其他

生物性骨材市場規模（按應用和複合年成長率） (2025-2032)

• 市場概覽
• 骨關節炎和骨關節炎
• 脊椎融合手術
• 骨折恢復
• 軟組織損傷
• 顎顏面和牙科應用

生物性骨材市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院及門診中心
• 研究和學術機構
• 牙醫診所

生物性骨材市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Stryker Corporation（USA）
• Medtronic plc（Ireland）
• Zimmer Biomet Holdings, Inc.（USA）
• DePuy Synthes（Johnson & Johnson）（USA）
• Bioventus LLC（USA）
• Arthrex, Inc.（USA）
• NuVasive, Inc.（USA）
• Orthofix International NV（Netherlands）
• Globus Medical, Inc.（USA）
• Kuros Biosciences AG（Switzerland）
• Xtant Medical Holdings, Inc.（USA）
• Harvest Technologies Corporation（USA）
• Wright Medical Group NV（Netherlands）
• Smith & Nephew plc（UK）
• Bone Biologics Corp.（USA）
• Sano Orthopedics（USA）

結論和建議

Global Orthobiologics Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 8.78 billion in 2024 to USD 13.79 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The orthobiologics market, encompassing products that enhance the healing of musculoskeletal conditions, is poised for significant growth driven by advancements in regenerative medicine, an aging population, and increasing orthopedic procedures. Key offerings include stem cells, bone grafts, and PRP (plasma-rich-platelet) therapies. However, challenges such as stringent regulatory approvals, lack of standardization, and high treatment costs may hinder market expansion. Despite these obstacles, the sector is set to flourish due to burgeoning opportunities in applications, increased research and development efforts, and a rising trend towards personalized medicine. As a result, the orthobiologics market is expected to experience notable growth through the forecast period, reflecting a dynamic and evolving landscape in treatment options for musculoskeletal health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segments Analysis

Global Orthobiologics Market is segmented by Product Type, Type, Application, End-user and region. Based on Product Type, the market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone morphogenetic protein (BMP), Viscosupplementation, Synthetic bone substitutes and Stem cell therapy. Based on Type, the market is segmented into Knee, Ankle, Hip, Wrist & Shoulder, Spine and Others. Based on Application, the market is segmented into Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications. Based on End-user, the market is segmented into Hospitals & Ambulatory Centers, Research & Academic Institute and Dental Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Orthobiologics Market

The global orthobiologics market is significantly driven by advancements in modern technologies and research and development efforts. Innovations in platelet-rich plasma (PRP), stem cell therapies, and various related techniques are enhancing the availability, access, and effectiveness of orthobiologics, thereby fueling market expansion. Furthermore, ongoing research and clinical trials are paving the way for the introduction of new treatment methods and products. These innovations not only promote faster healing but also contribute to better overall recovery outcomes, solidifying the positive trajectory of the orthobiologics market and attracting increasing interest from both healthcare providers and patients.

Restraints in the Global Orthobiologics Market

The expansion of the global orthobiologics market faces significant challenges primarily due to the demand for comprehensive research and the variability of outcomes associated with these therapies. Although advancements and promising developments in this field are evident, the insufficiency of thorough clinical studies demonstrating the effectiveness of various orthobiologics may limit their acceptance among healthcare providers. Furthermore, the inconsistency in results observed across multiple studies can foster doubt regarding the efficacy of certain products, ultimately influencing their widespread adoption and usage within medical practices. As a result, these factors collectively pose a restraint on market growth.

Market Trends of the Global Orthobiologics Market

The Global Orthobiologics market is witnessing a notable trend towards the increased adoption of Platelet-Rich Plasma (PRP) treatments, driven by its efficacy in treating joint pain, soft tissue injuries, and enhancing post-surgical recovery. This regenerative application of PRP is gaining traction among healthcare professionals and patients alike, fueled by the growing focus on minimally invasive procedures. Furthermore, initiatives aimed at standardizing PRP preparation and administration protocols are enhancing its credibility and reliability, leading to improved outcomes. As a result, this trend is expected to bolster the overall market growth, positioning PRP as a pivotal component of modern orthobiologic therapies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Orthobiologics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Demineralized Bone Matrix (DBM)
• Allograft
• Bone morphogenetic protein (BMP)
• Viscosupplementation
• Synthetic bone substitutes
• Stem cell therapy

Global Orthobiologics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Knee
• Ankle
• Hip
• Wrist & Shoulder
• Spine
• Others

Global Orthobiologics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Osteoarthritis & Degenerative Arthritis
• Spinal Fusion
• Fracture Recovery
• Soft Tissue Injuries
• Maxillofacial & Dental Applications

Global Orthobiologics Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals & Ambulatory Centers
• Research & Academic Institute
• Dental Clinics

Global Orthobiologics Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Application, End-user)
  • US
  • Canada
• Europe (Product Type, Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DePuy Synthes (Johnson & Johnson) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix International N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harvest Technologies Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bone Biologics Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sano Orthopedics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations